From: Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry—a historical cohort study
No. of observations
Expected value
SIR
95% CI
p-value
Total
38
35.1
1.08
0.74–1.43
0.649
Female
34
28.7
1.18
0.81–1.56
0.321